PSA screening for prostate cancer has been a controversial topic for some time, particularly in relation to older men. In 2008, the US Preventive Services Task Force recommended against routine ...
Re-examination of data collected during the European Randomised Study of Screening for Prostate Cancer (ERSPC) has confirmed and strengthened the primary conclusion of the original analysis. The ERSPC ...
The understanding of prostate cancer has significantly evolved in the past 15 years. Therefore, many people — including primary care providers — may not be aware of the current guidelines for prostate ...
Mortality in prostate cancer is lower in areas with frequent use of PSA testing compared with areas with little testing shows a study published online today in Journal of the National Cancer Institute ...
NEW ORLEANS, Louisiana — Prostate-specific antigen (PSA) is an imperfect screening biomarker for prostate cancer, but new data indicate that accounting for noncancer genetic factors that influence PSA ...
A national task force that issues guidelines for doctors says PSA testing should not be used to screen men for possible prostate cancer because it can lead to more harms than benefit You can save this ...
CINCINNATI (WKRC) - Defense Secretary Lloyd Austin’s diagnosis of prostate cancer has specialists reminding everyone about the importance of early detection. But, many men are still not getting the ...
WASHINGTON, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Vantage Market Research’s recent analysis of the Global Prostate Specific Antigen (PSA) Testing Market finds that rising prostate cancer among men, who ...
The PSA test is a blood test that detects the level of a protein called prostate specific antigen (PSA) in the blood. PSA is a protein produced by both normal and cancerous prostate cells and it is ...
The spontaneous PSA testing that has been applied in Sweden in recent decades has only had a marginal effect on mortality. An organized screening focused on those who have the most to gain would, ...
Shomik Sengupta treats men with prostate cancer both as a private practitioner and as an employee of Eastern Health. He has been a recipient of grant funding from Cancer Australia for clinical trials ...
According to a recent report by Consegic Business Intelligence, the Prostate Specific Antigen (PSA) testing market is poised for strong expansion and is expected to reach USD 9,701.66 million by 2030.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback